Comparison of long-term systemic and secretory antibody responses in children given live, attenuated, or inactivated influenza A vaccine.
about
Pre-clinical evaluation of a replication-competent recombinant adenovirus serotype 4 vaccine expressing influenza H5 hemagglutininNew aspects of influenza viruses.Antibody Persistence in Adults Two Years after Vaccination with an H1N1 2009 Pandemic Influenza Virus-Like Particle Vaccine.Reversion of Cold-Adapted Live Attenuated Influenza Vaccine into a Pathogenic VirusEngineering temperature sensitive live attenuated influenza vaccines from emerging viruses.Heightened adaptive immune responses following vaccination with a temperature-sensitive, live-attenuated influenza virus compared to adjuvanted, whole-inactivated virus in pigs.Influenza viruses with rearranged genomes as live-attenuated vaccines.Influence of prior influenza vaccination on antibody and B-cell responses.A respiratory syncytial virus (RSV) vaccine based on parainfluenza virus 5 (PIV5).Systems biology of vaccination for seasonal influenza in humans.Protective efficacy of low-dose amantadine in adults challenged with wild-type influenza A virus.Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines.The human side of influenza.Endogenous antigen processing drives the primary CD4+ T cell response to influenza.Roles of adjuvant and route of vaccination in antibody response and protection engendered by a synthetic matrix protein 2-based influenza A virus vaccine in the mouseAntigenic Maps of Influenza A(H3N2) Produced With Human Antisera Obtained After Primary InfectionImmunological principles and emerging strategies of vaccination for the elderly.Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines.Correlates of Immunity to Influenza as Determined by Challenge of Children with Live, Attenuated Influenza VaccineAnalysis of immunoglobulin G antibody responses after administration of live and inactivated influenza A vaccine indicates that nasal wash immunoglobulin G is a transudate from serum.Determination of antibody response to influenza virus surface glycoproteins by kinetic enzyme-linked immunosorbent assay.Live Attenuated Influenza Vaccine in Children Induces B-Cell Responses in Tonsils.Antibody responses after inactivated influenza vaccine in young children.Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine.Resistance of adults to challenge with influenza A wild-type virus after receiving live or inactivated virus vaccine.Evaluation of live avian-human reassortant influenza A H3N2 and H1N1 virus vaccines in seronegative adult volunteers.Comparison by studies in squirrel monkeys, chimpanzees, and adult humans of avian-human influenza A virus reassortants derived from different avian influenza virus donors.Use of live cold-adapted influenza A H1N1 and H3N2 virus vaccines in seropositive adultsThe elucidation of non-classical MHC class II antigen processing through the study of viral antigens.A novel particulate influenza vaccine induces long-term and broad-based immunity in mice after oral immunization.Effect of nitrogen dioxide exposure on susceptibility to influenza A virus infection in healthy adults.Evaluation of the humoral and cellular immune responses elicited by the live attenuated and inactivated influenza vaccines and their roles in heterologous protection in ferrets.H5N2 vaccine viruses on Russian and US live attenuated influenza virus backbones demonstrate similar infectivity, immunogenicity and protection in ferrets.
P2860
Q28731982-46DE057E-549E-49DC-A6E5-23D444DAADF0Q30333613-F03E0A86-2CC6-4C5F-B526-2E41D1B7AB37Q30384943-A7C38B50-DCD8-4516-9101-C7383D9EFB30Q30390811-64AA0D49-04C3-4CAC-9BF6-58272DE5DAAEQ30414665-3F1442AE-6A34-4199-9B5F-2F152F19C955Q30419702-427BBD40-7E43-445B-A890-834FB13E35C8Q30427712-977B6CCF-B767-48D9-9E06-D1700D4B3E54Q33361605-EAF0017D-05F1-4695-BF72-9E9A5927DC01Q33690612-A4A55CC0-2940-4A32-AF05-2BFDC99889F4Q35118722-D3ADF49D-2394-446D-BBBF-168052F8D93AQ35542114-620177F6-E640-4BE9-8426-1F905A882E09Q35634295-3EF05EFE-1C4F-49EE-BCB6-BE5FB7F1D19BQ36055988-53F5A1CC-8045-448B-A643-3B6D3B1015FFQ36240012-41B54890-EB05-4813-B1C9-01D09E48A9CFQ36345130-5C076826-DB53-4C6F-A98D-9AAE15C30461Q36365301-7404C6C1-0C4F-4FC2-BD9A-A4C3E5771F5CQ36728309-C723CB41-150E-4401-9920-EA3BB431029CQ36826849-10DA34E1-E170-4EFB-80A4-AC8CB5FE6998Q37091608-BF346255-9B3D-4506-973E-1B55621BEE0CQ37138345-F12F06E1-0018-49CF-A26F-2105AA1458A2Q37156330-A5756F47-85BE-479C-95F0-43F4BE43C1A4Q37161924-251CFA74-8621-4425-9D0F-3676B1384C56Q37173332-E5F50A83-5FF0-4FB0-930E-38DA34178B61Q37200967-3A0FE181-7A9A-406D-9D7C-585FF9085B34Q37200987-7E191C28-4B0B-4CAD-8174-35868582C6B1Q37204545-65F24A39-4682-4335-B086-8FFEF7102F03Q37209873-F73F7637-0B3E-449B-9E0F-56E478DE0431Q37228291-3A41F194-D25A-47E9-8682-AD82876284AFQ39084138-295324C4-E5D3-49E2-A6C4-CEE0B1422D53Q40064138-5BC0B8AD-FC48-4DA5-B3F4-B8BDEBBF9D3EQ40775393-BDD8FFA0-C676-4C9B-8847-B941AFFBD7B6Q44130165-11C32EE9-4AF6-45F7-81CB-8A6E361BD388Q52675104-BE09D08C-D999-4938-B048-0D2B7BDC5E62
P2860
Comparison of long-term systemic and secretory antibody responses in children given live, attenuated, or inactivated influenza A vaccine.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh-hant
name
Comparison of long-term system ...... activated influenza A vaccine.
@en
Comparison of long-term system ...... activated influenza A vaccine.
@nl
type
label
Comparison of long-term system ...... activated influenza A vaccine.
@en
Comparison of long-term system ...... activated influenza A vaccine.
@nl
prefLabel
Comparison of long-term system ...... activated influenza A vaccine.
@en
Comparison of long-term system ...... activated influenza A vaccine.
@nl
P2093
P2860
P356
P1476
Comparison of long-term system ...... activated influenza A vaccine.
@en
P2093
Johnson PR Jr
Mahoney JD
Thompson JM
P2860
P304
P356
10.1002/JMV.1890170405
P577
1985-12-01T00:00:00Z